SciELO - Scientific Electronic Library Online

 
vol.31 issue6The role of peritoneal dialysis in the treatment of ascitesAppendix to Dialysis Centre Guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals: Opinions from the Outpatient Dialysis Group author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Nefrología (Madrid)

On-line version ISSN 1989-2284Print version ISSN 0211-6995

Abstract

LAMAS BARREIRO, J.M.; ALONSO SUAREZ, M.; SAAVEDRA ALONSO, J.A.  and  GANDARA MARTINEZ, A.. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements. Nefrología (Madr.) [online]. 2011, vol.31, n.6, pp.656-663. ISSN 1989-2284.

Background: Despite the discrepancy in results from Spanish studies on the costs of dialysis, it is assumed that peritoneal dialysis (PD) is more efficient than haemodialysis (HD). Objectives: To analyse the costs and added value of HD and PD outsourcing agreements in Galicia, the medical transport for HD and the relationship between the cost of the agreement and the cost of consumables used in continuous ambulatory peritoneal dialysis (CAPD) with bicarbonate. Methods: The cost of the outsourcing agreements and the staff was obtained from official publications. The cost of PD and medical transport were calculated using health service data for one month and extrapolating it to one year. The cost of CAPD consumables was provided by the suppliers. The added value was calculated from the investments generated for each agreement treating 40 patients. Results: Expressed as patient/year, the mean costs for treatment were €21 595 and €25 664 in HD and PD, respectively. Medical transport varied between €3323 and €6338, while those of the CAPD agreement and consumables were €19 268 and €12 057, respectively. The added value was greater with the HD agreement, especially considering the jobs created. Conclusions: One cannot generalise that the cost of PD, which is significantly influenced by prescriptions, is lower than that of HD. It would be appropriate to review the additional cost to consumables in the CAPD agreement. The added value generated by dialysis agreements should be considered in future studies and in health planning. More controlled studies are needed to better understand this issue.

Keywords : Haemodialysis; Peritoneal dialysis; Costs.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License